Insider Selling: Receptos Director Sells 37,359 Shares of Stock (RCPT)
Receptos (NASDAQ:RCPT) Director William Rastetter sold 37,359 shares of the stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $30.85, for a total transaction of $1,152,525.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of Receptos (NASDAQ:RCPT) traded up 2.41% on Friday, hitting $30.96. 250,369 shares of the company’s stock traded hands. Receptos has a one year low of $13.00 and a one year high of $35.26. The stock has a 50-day moving average of $25.55 and a 200-day moving average of $22.76. The company’s market cap is $567.7 million.
Receptos (NASDAQ:RCPT) last posted its quarterly earnings results on Wednesday, October 30th. The company reported ($0.88) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.61) by $0.27. The company had revenue of $1.10 million for the quarter. Analysts expect that Receptos will post $-6.26 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Leerink Swann raised their price target on shares of Receptos to $45.00 in a research note to investors on Thursday, December 5th. Separately, analysts at Credit Suisse reiterated a “buy” rating on shares of Receptos in a research note to investors on Monday, November 18th. They now have a $31.00 price target on the stock. Finally, analysts at Wedbush raised their price target on shares of Receptos to $44.00 in a research note to investors on Monday, November 18th.
Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.